Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. (Q37946252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kenjiro Kotake

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

5

Yoshinori Ito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

15

Atsushi Ochiai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

4

Shinji Tanaka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

21

Takayuki Yoshino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

8

Ichinosuke Hyodo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Toshiaki Watanabe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Michio Itabashi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yasuhiro Shimada

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yoichi Ajioka

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Tetsuya Hamaguchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Masahiro Igarashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Hideyuki Ishida

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Megumi Ishiguro

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yukihide Kanemitsu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Norihiro Kokudo

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kei Muro

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Masahiko Oguchi

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yasuo Ohkura

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yoshiharu Sakai

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Hideki Ueno

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Takahiro Fujimori

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Nobuo Koinuma

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Takayuki Morita

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Genichi Nishimura

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Yuh Sakata

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Keiichi Takahashi

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Hiroya Takiuchi

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Osamu Tsuruta

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Toshiharu Yamaguchi

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Masahiro Yoshida

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Naohiko Yamaguchi

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Kenichi Sugihara

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Japanese Society for Cancer of the Colon and Rectum

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

15 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

1-29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22002491%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10147-011-0315-2

14 January 2020

exact match

0 references

cites work

Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection

1 reference

12 December 2020

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

1 reference

12 December 2020

Mesorectal excision for rectal cancer

1 reference

12 December 2020

Surgical treatment of hepatic and pulmonary metastases from colorectal cancers.

1 reference

12 December 2020

Detection and surveillance of colorectal cancer

1 reference

12 December 2020

Mechanisms of improved survival from intensive followup in colorectal cancer: a hypothesis.

1 reference

12 December 2020

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining

1 reference

12 December 2020

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients

1 reference

12 December 2020

Improved survival with preoperative radiotherapy in resectable rectal cancer

1 reference

12 December 2020

Consensus statement of definitions for anorectal physiology and rectal cancer: report of the Tripartite Consensus Conference on Definitions for Anorectal Physiology and Rectal Cancer, Washington, D.C., May 1, 1999.

1 reference

12 December 2020

Surveillance after colorectal cancer resection

1 reference

12 December 2020

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

1 reference

12 December 2020

Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group

1 reference

12 December 2020

Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial

1 reference

12 December 2020

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

1 reference

12 December 2020

Resection of both hepatic and pulmonary metastases in patients with colorectal carcinoma

1 reference

12 December 2020

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

12 December 2020

Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?

1 reference

12 December 2020

Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089.

1 reference

12 December 2020

The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?

1 reference

12 December 2020

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

1 reference

12 December 2020

Total mesorectal excision in the operative treatment of carcinoma of the rectum

1 reference

12 December 2020

Indication and benefit of pelvic sidewall dissection for rectal cancer.

1 reference

12 December 2020

The TME Trial After a Median Follow-up of 6 Years

1 reference

12 December 2020

Endoscopic mucosal resection of flat and depressed types of early colorectal cancer

1 reference

12 December 2020

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

1 reference

12 December 2020

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

12 December 2020

Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer

1 reference

12 December 2020

KRASMutation Signature in Colorectal Tumors Significantly Overlaps With the Cetuximab Response Signature

1 reference

12 December 2020

Follow-up of patients with curatively resected colorectal cancer: a practice guideline

1 reference

12 December 2020

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

1 reference

12 December 2020

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

1 reference

12 December 2020

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial

1 reference

12 December 2020

Conditions of curability after endoscopic resection for colorectal carcinoma with submucosally massive invasion

1 reference

12 December 2020

Follow-up strategies for patients treated for non-metastatic colorectal cancer

1 reference

12 December 2020

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

1 reference

12 December 2020

Local therapy of rectal tumors

1 reference

12 December 2020

Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer

1 reference

12 December 2020

Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer

1 reference

12 December 2020

Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer

1 reference

12 December 2020

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis

1 reference

12 December 2020

Risk factors for an adverse outcome in early invasive colorectal carcinoma.

1 reference

12 December 2020

Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials

1 reference

12 December 2020

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study

1 reference

12 December 2020

Interval hepatic resection of colorectal metastases improves patient selection

1 reference

12 December 2020

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

12 December 2020

Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study

1 reference

12 December 2020

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

1 reference

12 December 2020

Cetuximab for the treatment of colorectal cancer.

1 reference

12 December 2020

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

12 December 2020

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

12 December 2020

NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer

1 reference

12 December 2020

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

1 reference

12 December 2020

Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer

1 reference

12 December 2020

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

1 reference

12 December 2020

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

12 December 2020

Preoperative versus postoperative chemoradiotherapy for rectal cancer

1 reference

12 December 2020

Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer

1 reference

12 December 2020

Follow-up after curative resection of colorectal cancer: a meta-analysis

1 reference

12 December 2020

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

1 reference

12 December 2020

Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial

1 reference

12 December 2020

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV

1 reference

12 December 2020

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

12 December 2020

Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study.

1 reference

12 December 2020

EPIC: phase III trial of cetuximab plus irinotecan after fluoropyrimidine and oxaliplatin failure in patients with metastatic colorectal cancer

1 reference

12 December 2020

Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90-01 randomized trial

1 reference

12 December 2020

Colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up

1 reference

12 December 2020

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

1 reference

12 December 2020

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study

1 reference

12 December 2020

KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.

1 reference

12 December 2020

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study

1 reference

12 December 2020

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer

1 reference

12 December 2020

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer

1 reference

12 December 2020

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

12 December 2020

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

12 December 2020

A randomized trial of surgery in the treatment of single metastases to the brain.

1 reference

12 December 2020

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials

1 reference

12 December 2020